<DOC>
	<DOCNO>NCT01860482</DOCNO>
	<brief_summary>The purpose study assess efficacy safety Newrabell® Tab . patient refractory reflux esophagitis prior standard PPIs regimen .</brief_summary>
	<brief_title>The Study Evaluate Efficacy Safety Newrabell® Tab . ( Rabeprazole Sodium ) 10mg b.i.d Refractory GERD</brief_title>
	<detailed_description />
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Esophagitis , Peptic</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<criteria>1 . Male Female age ≥ 20 year 2 . Reflux esophagitis erosion ulceration confirm endoscopic exam . 3 . Refractory reflux esophagitis PPIs standard treatment follow 1 . Ongoing heartburn symptom without GERDrelated symptom : Regurgitation , Noncardiac chest pain , Epigastric pain , Belching , Bloating , Satiety , Sore throat , Cough , Laryngitis , Hoarseness , Nausea , Vomiting , Dysphagia , Odynophagia , Weight loss 2 . Ongoing heartburn symptom without erosion ≥ grade A accord LA Classification 4 . Ongoing heartburn symptom ≥ 2 day 1week right administer first dose IP 5 . Decided participate sign informed consent form willingly 1 . Existence upper gastrointestinal bleeding active gastroduodenal ulcer screen 2 . History operation esophagus , stomach duodenum 3 . The following medical history 1 . Primary esophageal motility disease , Achalasia , Scleroderma , Esophageal/pyloric stricture , Primary esophageal spasm 2 . Barrett 's esophagus ≥ 3 cm 3 . ZollingerEllison syndrome 4 . Infectious inflammatory bowel disease , Severe malabsorption 4 . Severe chronic heart failure , cardiovascular disease , renal failure , COPD , asthma , liver cirrhosis 5 . History cancer within 5 year , except completely recover skin cancer 6 . ALT AST ≥ Upper limit normal range X 3 7 . Need antibiotic due severe infection 8 . Severe medical disease need prohibit medication Anticoagulant ( Heparin , Warfarin , etc . ) , High dose aspirin ( &gt; 325mg/d ) , Digitalis ( Digoxin , etc . ) , Diuretics , Atazanavir , NSAIDs Steroids 9 . Use PPIs H2RA medicine within 1 week administer first dose IP , need PPIs H2RA medicine trial period 10 . Allergy hypersensitivity IP similar chemical structure ( Benzimidazol derivative , etc . ) 11 . Pregnant breastfeed woman 12 . Conversation impairment alcohol , drug addiction mental illness , etc . 13 . Administration IP within 28 day 14 . Inability record heartburn diary card 15 . In investigator 's judgement</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Refractory Reflux Esophagitis</keyword>
	<keyword>GERD</keyword>
	<keyword>Phase 4</keyword>
</DOC>